The CVCTU supports Clinical Trials of Investigational Medicinal Products (CTIMPs), non-CTIMPs (which include trials of complex interventions) and device studies, whether these are single-centre, multi-centre, national or international studies. The aim is to support local investigators to deliver high-quality trials by providing oversight of the main trial activities. The CVCTU is a core resource providing infrastructure support for clinical cardiovascular research.
If you wish to have the Barts CVCTU as your official trials unit for a study, it will provide oversight of the main trial activities, and also provide specific resource services as requested, which may include:
Trial design, risk assessment, costings, protocol development, obtaining approvals (MHRA, NRES, NHS), regulatory and ethics submissions, statistical design and analysis, study oversight, data management, database development and CRF design, randomisation and unblinding, patient and public involvement, IMP management, and recruitment of study staff.
If you are interested in seeking our advice or collaborating with us on a study, please get in touch by phone or email. We recommend making contact at an early stage and preferably at the point of grant application development. By contacting us early this will enable you to take full advantage of our wealth of experience and expertise, and increases the likelihood of a successful application.
Our CVCTU Flowchart [PDF 41KB] explains the current procedure if you would like our clinical Trials Unit support for your study.
This will then be reviewed by the CVCTU Scientific & Resource Committees.
Please aim to submit your enquiry form to us 8 weeks prior to the funding deadline for a full submission, and at least 4 weeks prior for an outline funding submission, otherwise we cannot guarantee to provide a complete review and response by your application deadline.